SIStockInvestingSI.com

NYSE · WAT · Diagnostics & Research

Waters Corporation (WAT) stock analysis

$457.47+3.31%Data as of Oct 21, 2026
  • WAT gained 7.5% over the past month versus 0.0% for the S&P 500, ranking 107th of 497 S&P 500 stocks.
  • Over 12 months it returned +33.3%, 17.5 points ahead of the S&P 500, and trades 0.0% below its 52-week high.
  • In the last 30 days 0 analysts raised earnings estimates and 2 cut; forward EPS moved −0.1% (+0.2% over 90 days).
  • It sits in the Laboratory & analytical tools segment of the Medtech, Diagnostics & Care, where the 1-month median return is +6.4%.
  • The daily chart reads Intermediate uptrend · Trend advance (since Oct 21, 2026).
Market cap$44.9B
12-month return+33.3%
Forward P/E27.6×
Mean target vs price+1.5%

One-year price with 50- and 200-day averages

Open in Hub
297346395444JanAprJulOct
457.4750-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

WAT+7.5%
Sector median−8.7%
S&P 5000.0%
WAT+19.6%
Sector median−5.4%
S&P 500+4.7%
WAT+36.8%
Sector median−1.5%
S&P 500+8.7%
WAT+33.3%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 500107 / 497
3-month rank in its sector · Healthcare149 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Intermediate uptrend · Trend advanceConfirmed

Holding since Oct 21, 2026

  • Close above EMA20 above EMA50
  • EMA50 rose over the last ten sessions
  • Some swings conflict with the averages
This pattern on this stock

66 occurrences in 10 years. The median move over the next 20 sessions was −0.1%, positive 48% of the time, against +1.2% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$16.53
30-day change−0.1%
90-day change+0.2%
Mean target$464.30 +1.5%
Raised (30d) 0Cut (30d) 2

23 analysts cover the stock

Fundamental shape vs peers

Six dimensions on fixed scales. The filled shape is the company; the outline is the peer average.

Open the full Radar with every ratio
ValuationRevisionsMomentumGrowthCashProfit

Ahead of peersGrowth

Behind peersCash, Momentum

PeersTMO · DHR · NTRA · A

Where it sits in the supply chain

Medtech, Diagnostics & Care · Tools & research

Explore the full chain map in Hub
Its segment
Laboratory & analytical tools+6.4%
TMO+5.4%1 monthDHR+6.0%1 monthA+6.4%1 monthWAT+7.5%1 monthMTD+12.6%1 monthRVTY+9.3%1 monthTECH+0.1%1 month

Instruments and reagents serve research and labs; budgets and inventories affect orders.

Sells into
Clinical laboratory services+3.0%
LH+3.9%1 monthDGX+2.2%1 month
Research & clinical outsourcing+11.7%
CRL+21.0%1 monthIQV+2.4%1 month

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−31.3%
Volatility, 60D26.2%
From 52-week high0.0%
From 52-week low+61.5%
Trailing P/E115.8×
Forward P/E27.6×
TMOThermo Fisher ScientificDHRDanaherAAgilent Technologies, Inc.MTDMettler-Toledo International, IRVTYRevvity, Inc.TECHBio-Techne CorpLHLabcorp Holdings Inc.DGXQuest Diagnostics Incorporated

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗